Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ)
CNY 18.81
(9.49%)
CNY 18.81
(9.49%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.79 Billion CNY | 11.58% |
| 2022 | 1.6 Billion CNY | 17.41% |
| 2021 | 1.36 Billion CNY | 17.63% |
| 2020 | 1.16 Billion CNY | -3.64% |
| 2019 | 1.2 Billion CNY | 62.11% |
| 2018 | 744.03 Million CNY | -0.52% |
| 2017 | 747.95 Million CNY | 19.15% |
| 2016 | 627.74 Million CNY | 8.28% |
| 2015 | 579.76 Million CNY | 125.39% |
| 2014 | 257.23 Million CNY | -9.07% |
| 2013 | 282.89 Million CNY | 36.67% |
| 2012 | 206.98 Million CNY | 18.2% |
| 2011 | 175.11 Million CNY | -10.5% |
| 2010 | 195.65 Million CNY | 20.31% |
| 2009 | 162.62 Million CNY | 90.93% |
| 2008 | 85.17 Million CNY | 69.48% |
| 2007 | 50.25 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.77 Billion CNY | -0.64% |
| 2024 Q3 | 2.47 Billion CNY | 9.85% |
| 2024 Q2 | 2.25 Billion CNY | 26.76% |
| 2023 Q1 | 1.44 Billion CNY | -10.02% |
| 2023 FY | 1.79 Billion CNY | 11.58% |
| 2023 Q2 | 1.56 Billion CNY | 8.7% |
| 2023 Q3 | 1.57 Billion CNY | 0.18% |
| 2023 Q4 | 1.79 Billion CNY | 13.88% |
| 2022 Q2 | 1.59 Billion CNY | 27.18% |
| 2022 Q4 | 1.6 Billion CNY | -10.43% |
| 2022 FY | 1.6 Billion CNY | 17.41% |
| 2022 Q3 | 1.79 Billion CNY | 12.15% |
| 2022 Q1 | 1.25 Billion CNY | -8.1% |
| 2021 Q4 | 1.36 Billion CNY | 11.55% |
| 2021 Q1 | 1.29 Billion CNY | 11.01% |
| 2021 FY | 1.36 Billion CNY | 17.63% |
| 2021 Q2 | 1.29 Billion CNY | 0.27% |
| 2021 Q3 | 1.22 Billion CNY | -5.26% |
| 2020 Q1 | 1.31 Billion CNY | 9.27% |
| 2020 Q2 | 1.27 Billion CNY | -2.99% |
| 2020 FY | 1.16 Billion CNY | -3.64% |
| 2020 Q4 | 1.16 Billion CNY | -3.17% |
| 2020 Q3 | 1.2 Billion CNY | -6.12% |
| 2019 Q2 | 984.89 Million CNY | 12.0% |
| 2019 Q1 | 879.39 Million CNY | 18.19% |
| 2019 FY | 1.2 Billion CNY | 62.11% |
| 2019 Q4 | 1.2 Billion CNY | 30.35% |
| 2019 Q3 | 925.29 Million CNY | -6.05% |
| 2018 Q1 | 697.79 Million CNY | -6.71% |
| 2018 Q4 | 744.03 Million CNY | -4.62% |
| 2018 Q3 | 780.04 Million CNY | 18.73% |
| 2018 FY | 744.03 Million CNY | -0.52% |
| 2018 Q2 | 656.99 Million CNY | -5.85% |
| 2017 Q3 | 750.13 Million CNY | 9.33% |
| 2017 Q2 | 686.14 Million CNY | 10.98% |
| 2017 Q1 | 618.26 Million CNY | -1.51% |
| 2017 FY | 747.95 Million CNY | 19.15% |
| 2017 Q4 | 747.95 Million CNY | -0.29% |
| 2016 Q1 | 569.76 Million CNY | -1.72% |
| 2016 Q2 | 588.2 Million CNY | 3.24% |
| 2016 Q3 | 599.66 Million CNY | 1.95% |
| 2016 Q4 | 627.74 Million CNY | 4.68% |
| 2016 FY | 627.74 Million CNY | 8.28% |
| 2015 Q4 | 579.76 Million CNY | 34.41% |
| 2015 Q2 | 495.18 Million CNY | 91.23% |
| 2015 Q1 | 258.95 Million CNY | 0.67% |
| 2015 FY | 579.76 Million CNY | 125.39% |
| 2015 Q3 | 431.34 Million CNY | -12.89% |
| 2014 Q1 | 272.85 Million CNY | -3.55% |
| 2014 FY | 257.23 Million CNY | -9.07% |
| 2014 Q2 | 237.61 Million CNY | -12.91% |
| 2014 Q4 | 257.23 Million CNY | 8.51% |
| 2014 Q3 | 237.05 Million CNY | -0.24% |
| 2013 Q2 | 222.21 Million CNY | 14.42% |
| 2013 Q3 | 249.14 Million CNY | 12.12% |
| 2013 Q1 | 194.2 Million CNY | -6.18% |
| 2013 Q4 | 282.89 Million CNY | 13.54% |
| 2013 FY | 282.89 Million CNY | 36.67% |
| 2012 Q1 | 184.23 Million CNY | 5.21% |
| 2012 Q2 | 240.86 Million CNY | 30.74% |
| 2012 Q3 | 169.53 Million CNY | -29.61% |
| 2012 FY | 206.98 Million CNY | 18.2% |
| 2012 Q4 | 206.98 Million CNY | 22.09% |
| 2011 Q3 | 154.89 Million CNY | -2.3% |
| 2011 Q1 | 125.1 Million CNY | -36.06% |
| 2011 Q2 | 158.53 Million CNY | 26.72% |
| 2011 Q4 | 175.11 Million CNY | 13.06% |
| 2011 FY | 175.11 Million CNY | -10.5% |
| 2010 Q2 | 118.48 Million CNY | 0.0% |
| 2010 FY | 195.65 Million CNY | 20.31% |
| 2010 Q4 | 195.65 Million CNY | 67.77% |
| 2010 Q3 | 116.62 Million CNY | -1.57% |
| 2009 FY | 162.62 Million CNY | 90.93% |
| 2009 Q4 | 162.62 Million CNY | 0.0% |
| 2008 FY | 85.17 Million CNY | 69.48% |
| 2007 FY | 50.25 Million CNY | 0.0% |